Article
Yeast based small molecule screen for inhibitors of SARS-CoV.
PloS one - 1 Jan 2011
Frieman Matthew, Basu Dipanwita, Matthews Krystal, Taylor Justin, Jones Grant, Pickles Raymond, Baric Ralph, Engel Daniel A
Abstract excerpt
Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is an attractive target for pharmaceutical development because it is essential for virus replication and is conserved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
